Literature DB >> 3310074

An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom.

P Ispahani1, N J Pearson, D Greenwood.   

Abstract

A total of 875 episodes of bacteraemia and fungaemia were analysed in patients admitted to University Hospital, Nottingham, and three smaller hospitals over a four-year period. In 814 episodes (93 per cent) a single organism was isolated, most commonly Escherichia coli (27.4 per cent), other enterobacteria (14.4 per cent), Staphylococcus aureus (11.2 per cent), Streptococcus pneumoniae (9.0 per cent), or Haemophilus influenzae (6.4 per cent). In 61 cases (7.0 per cent) bacteraemia was due to two or more species. In almost 60 per cent of cases, bacteraemia was considered to be community-acquired. The most common sources were the urinary (26.9 per cent), respiratory (14.6 per cent), gastrointestinal (11.6 per cent) and biliary (9.5 per cent) tracts, but in almost 10 per cent of cases the focus of infection was unknown. Polymicrobial bacteraemia was common when the biliary tract was the focus of infection. Shock was recorded in 19.5 per cent of cases, and was commoner in polymicrobial (42.9 per cent) than in monomicrobial (17.4 per cent) episodes. In monomicrobial episodes haemolytic streptococci were associated with the highest incidence of shock (30.0 per cent). Mortality directly related to bacteraemia (19.5 per cent) was higher with Gram-positive (23.5 per cent) than with Gram-negative (15.8 per cent) organisms; in polymicrobial (31.1 per cent) than in monomicrobial episodes (18.7 per cent); and in those who had multiple episodes (34.7 per cent) than in those who had a single episode of bacteraemia (20.3 per cent). Other factors influencing mortality included shock, failure to mount an adequate febrile response, leucopenia or granulocytopenia, and underlying disease. Mortality was markedly reduced by appropriate treatment; a single antimicrobial agent was as effective as combination therapy in bacteraemia caused by Gram-negative bacilli.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310074

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  29 in total

1.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Do streptococci cause toxic shock?

Authors:  J Cohen; K Bayston; M Tomlinson
Journal:  BMJ       Date:  1990-12-01

Review 3.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  Improving early management of bloodstream infection: a quality improvement project.

Authors:  Jane Minton; James Clayton; Jonathan Sandoe; Hugh Mc Gann; Mark Wilcox
Journal:  BMJ       Date:  2008-02-23

5.  Gas gangrene.

Authors:  P J Lehner; H Powell
Journal:  BMJ       Date:  1991-07-27

6.  An international multicenter study of blood culture practices. The International Collaborative Blood Culture Study Group.

Authors:  J A Washington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

Review 7.  Postmarketing surveillance of quinolones, 1990 to 1992.

Authors:  P Davey; T McDonald
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Two rules for early prediction of bacteremia: testing in a university and a community hospital.

Authors:  Y Yehezkelli; S Subah; G Elhanan; R Raz; A Porter; A Regev; L Leibovici
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

Review 9.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

10.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.